Table 1 Demographic and clinical data of recurrent fallers with Parkinson’s disease.

From: Falling Direction can Predict the Mechanism of Recurrent Falls in Advanced Parkinson’s Disease

 

Total fallers (n = 62)

Forward fallers (n = 45)

Non-forward fallers (n = 17)

p-value

Age, years

70.5 ± 7.9

69.9 ± 7.9

72.2 ± 8.0

0.602

Gender, male/female

32/30

25/20

7/10

0.739

Disease duration, years

11.3 ± 4.1

11.4 ± 4.1

10.8 ± 4.4

0.632

LED, mg/day

876.0 ± 359.3

904.8 ± 386.5

800.0 ± 270.0

0.236

HY (On)

2.3 ± 0.7

2.3 ± 0.7

2.4 ± 0.7

0.595

UPDRS part 3

22.5 ± 9.3

23.0 ± 9.8

21.1 ± 8.1

0.447

Subtype, TD/AR/MX, n(%)

8/54/0 (12.9/87.1/0)

7/38/0 (15.6/84.4/0)

1/16/0 (5.9/94.1/0)

0.427

Camptocormia, n (%)

9 (14.5)

5 (11.1)

4 (23.5)

0.242

Pisa syndrome, n (%)

13 (21.0)

9 (20)

4 (23.5)

0.242

Dyskinesia, n (%)

21 (32.8)

16 (32.7)

5 (33.3)

0.551

Wearing off, n (%)

34 (54.8)

26 (57.8)

8 (47.1)

0.570

FOG, n (%)

46 (74.2)

36 (80)

10 (58.8)

0.111

FOGQ total score

11.2 ± 5.2

12.2 ± 5.0

8.7 ± 5.2

0.022

FOGQ, sum of items 3-6

6.5 ± 4.3

7.3 ± 4.2

4.4 ± 4.1

0.019

Tinnetti balance score

12.8 ± 3.3

12.9 ± 3.2

12.4 ± 3.4

0.514

FAB

12.4 ± 3.2

12.9 ± 2.9

12.2 ± 3.1

0.475

NPI

9.8 ± 13.6

8.1 ± 12.2

14.2 ± 16.2

0.106

  1. PD, Parkinson’s disease; LED, daily levodopa equivalent dose; HY, Hoehn and Yahr stage; UPDRS, unified Parkinson’s disease rating scale; FOG, freezing of gait; FOGQ, freezing of gait questionnaire; FAB, frontal assessment battery; NPI, neuropsychiatric inventory.